Monica Key, APRN, CCRN, AOCNP

Just when you think you've run out of treatment options for a patient, new drugs are approved and quickly available. In the past year, there have been dozens of new drugs for all types of solid and blood malignancies. One of the most recent was just approved this year for breast cancer.

Recently, I attended an event sponsored by Bristol-Myers Squibb featuring a medical oncologist who shared his experiences with nivolumab. An interesting observation he shared was that the side effects seem to be slightly different in patients with melanoma compared to those with NSCLC.